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Abstract
Background—Methods of measuring influenza vaccination of healthcare personnel (HCP) vary 
substantially, including which groups of HCP are included in measurements. Thus, comparison of 
vaccination rates across healthcare facilities is difficult.
Purpose—The goal of the study was to determine the feasibility of implementing a standardized 
measure for reporting HCP influenza vaccination data in various types of healthcare facilities.
Methods—A total of 318 facilities recruited in four U.S. jurisdictions agreed to participate in the 
evaluation, including hospitals, long-term care facilities, dialysis clinics, ambulatory surgery 
centers, and physician practices. HCP in participating facilities were categorized as employees, 
credentialed non-employees, or other non-employees using standard definitions. Data were 
gathered using cross-sectional web-based surveys completed at three intervals between October 
2010 and May 2011 and analyzed in February 2012.
Results—234 facilities (74%) completed all three surveys. Most facilities could report on-site 
employee vaccination; almost one third could not provide complete data on HCP vaccinated 
outside the facility, contraindications, or declinations, primarily due to missing non-employee 
data. Inability to determine vaccination status of credentialed and other non-employees was cited 
as a major barrier to measure implementation by 24% and 27% of respondents, respectively.
Conclusions—Using the measure to report employee vaccination status was feasible for most 
facilities; tracking non-employee HCP was more challenging. Based on evaluation findings, the 
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measure was revised to limit the types of non-employees included. Although the revised measure 
is less comprehensive, it is more likely to produce valid vaccination coverage estimates. Use of 
this standardized measure can inform quality improvement efforts and facilitate comparison of 
HCP influenza vaccination among facilities.
Introduction
Influenza is a leading cause of mortality in the U.S., contributing to an estimated average of 
23,607 deaths annually from 1976 to 2007.1 Influenza outbreaks can have substantial 
consequences for healthcare facilities, including prolonged hospital stays, increased patient 
mortality, and disruption of care provision.2–6 Influenza vaccination prevents influenza-
related illness and work absence among healthcare personnel (HCP)2,7–12 and is associated 
with reduced influenza illness6,9,10,13–16 and death10,13,14,17,18 in their patients.
Measurement of HCP influenza vaccination coverage is an important healthcare quality 
indicator. The Joint Commission, National Foundation for Infectious Diseases, Society for 
Healthcare Epidemiology of America (SHEA); and the Advisory Committee on 
Immunization Practices (ACIP) and Healthcare Infection Control Practices Advisory 
Committee (HICPAC) of the CDC recommend including such measurement as a component 
of healthcare facility influenza vaccination programs.19–22 SHEA and ACIP/HICPAC 
further recommend regularly reporting HCP influenza vaccination coverage to facility 
administrators and staff.21,22
The Joint Commission recently revised its influenza vaccination standard to require a variety 
of healthcare organizations to measure and report influenza vaccination coverage among 
staff and licensed independent practitioners as a condition of accreditation.23 The Task 
Force on Community Preventive Services recommends provider assessment and feedback as 
a strategy to improve vaccination coverage in various populations and settings.24 Even 
voluntary reporting can improve vaccination coverage levels: median employee influenza 
vaccination coverage at hospitals participating in a voluntary statewide reporting program 
increased by 20 percentage points over 4 years.25
The National Quality Forum (NQF), a voluntary consensus standards-setting organization 
dedicated to healthcare quality improvement, gave provisional endorsement to a CDC-
sponsored standardized measure of HCP influenza vaccination in 2008 (Measure 0431). The 
measure’s intent was to ensure that reported HCP influenza vaccination was comprehensive 
within a single facility and comparable across facilities. Measures considered for full 
endorsement by NQF must undergo pilot testing to evaluate four major criteria: importance 
of measurement and reporting; scientific acceptability (i.e., validity and reliability); 
usability; and feasibility.26 The objectives of the current report are to describe results of a 
pilot test to determine the feasibility of implementing the provisional measure, to outline 
revisions made to the measure as a result of the pilot, and to explain how the revised 
measure will be used nationally. (Validity and reliability of the measure are described 
elsewhere.27)
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Methods
The CDC, in conjunction with four jurisdictions, recruited 318 healthcare facilities to 
participate in the pilot. Facilities were recruited by project staff in each of the jurisdictions 
via telephone, mail, fax, and e-mail. Some facilities were recruited from existing networks 
involved in healthcare surveillance, state/local professional associations and umbrella 
organizations, and connections from prior collaborations. Eligible facilities included acute 
care hospitals; long-term care facilities (LTCFs); dialysis clinics; ambulatory surgery centers 
(ASCs); and physician practices. Recruitment goals and specific inclusion and exclusion 
criteria for each facility type were defined in a written protocol. The pilot testing took place 
during the 2010–2011 influenza season (defined as October 1, 2010–March 31, 2011). The 
pilot was determined to be public health nonresearch by CDC and by participating 
jurisdictions, as required.
Measure Specifications
Participating facilities reported counts for vaccination status (numerator) and total number of 
HCP (denominator), which were used to calculate facility-level vaccination coverage. The 
numerator consisted of four mutually exclusive categories of HCP: vaccinated at the 
healthcare facility, vaccinated elsewhere, had a medical contraindication to influenza 
vaccination, and declined vaccination. The total for the denominator consisted of all HCP 
who worked at the facility full- or part-time for ≥1 day during influenza season, reported in 
three mutually exclusive groups: employees, credentialed non-employees, and other non-
employees.
Employees were defined as those who received a paycheck directly from the healthcare 
facility. Credentialed non-employees (CNE) were defined as licensed practitioners affiliated 
with the facility who did not receive a paycheck from the facility; these included physicians 
or mid-level providers with clinical or admitting privileges and technicians or therapists with 
professional credentialing. Other non-employees (ONE) were defined as those who did not 
receive a paycheck from the facility and did not count as CNE, including, but not limited to, 
contractors; students and trainees; resident physicians and fellows (if not paid by the 
facility); and volunteers. Level of patient contact was not assessed for any HCP.
Facilities were asked to report numerator data separately for each of the three HCP groups. 
Vaccination coverage for each denominator group was calculated by dividing the sum of 
HCP vaccinated at the facility and HCP vaccinated elsewhere by the denominator total for 
that group and multiplying by 100.
Data Collection and Analysis
Participating facilities completed surveys via a secure, web-based data collection tool hosted 
by CDC. Primary outcomes were numerator and denominator data as described above, 
perceived ease of reporting, and barriers to reporting HCP vaccination using the measure. 
Survey items about ease of use and reporting barriers were developed based on semi-
structured interviews conducted among a volunteer subset of 31 participating facilities.28 
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Participants also reported facility characteristics, data sources, and characteristics of their 
HCP influenza vaccination programs.
Healthcare facilities were asked to report numerator and denominator data at three time 
points: (1) denominator data by October 31, 2010; (2) numerator and denominator data as of 
December 31, 2010; and (3) numerator and denominator data as of March 31, 2011. Reports 
were cumulative, so data reported at the end of the season represented the total vaccination 
coverage level achieved by the facility. Influenza vaccinations received by HCP since 
August 2010 were included in the numerator. Facilities were instructed to include in their 
reports HCP who began work at the facility after October 1 or who ceased working before 
March 31. Descriptive statistics were calculated using SAS 9.2. Analyses were completed in 
February 2012.
Results
Sample
Of 318 facilities recruited, 88% (n=281) completed the first survey; 91% of those (n=257) 
completed the second survey. Of the remaining facilities, 91% (n=234) completed the final 
survey for a cumulative response rate of 74%. Response rates ranged from 53% among 
ASCs to 85% among hospitals. Facilities completing all three surveys did not differ from 
facilities completing only the first survey by size, ownership, urban location, or years 
offering influenza vaccine to HCP. However, facilities with less experience measuring HCP 
influenza vaccination were less likely to complete all surveys. Characteristics of facilities 
that completed the pilot are described in Table 1.
Ability to Report Using National Quality Forum Measure
Generally, facilities perceived the measure favorably, with over 70% reporting that the 
measure was comprehensive and easy to use and that measure instructions were easy to 
understand (Table 2). More than 80% of respondents reported that it was “easy” or “very 
easy” to assign employees to the correct denominator group; a much lower proportion 
reported that it was “easy” or “very easy” to assign CNE and ONE to the correct group.
Although all participating facilities were able to report denominator data for employees, 
about 10% of facilities could not provide denominator data for CNE or ONE (see 
Appendix). For numerator data, most facilities provided information on vaccinations at the 
facility; other numerator categories were more challenging. One third or more of facilities 
could not report data on vaccinations outside the facility, medical contraindications, or 
declinations for non-employees. Ability to report data for non-employees varied by facility 
type.
Barriers to Using National Quality Forum Measure
Barriers to using the provisional measure to report HCP influenza vaccination were assessed 
in the second and third surveys, in order to capture changes resulting from increased 
familiarity with the measure. Results were similar in the two surveys, so proportions from 
the third survey are reported (Table 3). The primary barriers reported by respondents 
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pertained to non-employees: inability to determine vaccination status of CNE and ONE was 
identified as a major barrier by 24% and 27% of facilities, respectively. Inability to 
determine which HCP were vaccinated outside the facility was identified as a major barrier 
by 21% of all facilities. A little more than 20% of all facilities reported that the time 
required to collect data on CNE and ONE was a major barrier to using the measure, and 
21% identified the number of ONE at the facility as a major barrier. Barriers varied by 
facility type; in general, dialysis clinics and physician practices reported barriers less 
frequently than other facilities.
Discussion
Reporting employee vaccination status using the standardized measure was feasible for 
various inpatient and outpatient healthcare facilities, whereas tracking vaccination status 
among non-employee HCP was more challenging. Although most pilot facilities stated that 
the provisional measure was easy to use, about one third could not fully report non-
employee vaccination data. The most commonly reported barrier to measure use was 
inability to determine vaccination status of non-employee HCP. Perceived barriers and 
ability to report vaccination data varied by facility type.
Implementing standardized measurement processes for HCP influenza vaccination can 
confer multiple benefits to healthcare facilities. Increases in HCP influenza vaccination 
coverage following initiation of measurement programs have been repeatedly observed, 
although the effect of measurement cannot be separated from other policies or activities 
implemented in conjunction with vaccination measurement.25,29,30 Observed coverage 
increases may be partially attributable to improved tracking of vaccinations received outside 
the healthcare facility.31 In addition, use of standardized HCP definitions increases the 
accuracy and comparability of vaccination coverage estimates; definitions that are not 
standardized can produce substantially different estimates of influenza vaccination coverage 
in the same population.32
An increased ability to generate accurate estimates of HCP influenza vaccination may help 
facilities reach vaccination coverage goals set either internally or externally. Another 
potential benefit is greater ease in complying with institutional, state, and national reporting 
requirements. These are becoming increasingly common now that HCP influenza 
vaccination has been identified as a recommended measure for healthcare quality 
reporting.33,34
It is not surprising that facilities reported greater difficulty measuring influenza vaccination 
coverage among non-employee HCP than among employees. A substantial proportion of 
U.S. hospitals do not include non-employee HCP in their coverage measurements.35 
Although employee counts can easily be determined using payroll records, numerous data 
sources may be necessary for tracking non-employees, particularly in larger healthcare 
facilities.
In the current study, acute care hospitals were particularly likely to report number of non-
employees and time required to collect non-employee vaccination data as major barriers to 
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using the measure. This is likely because hospitals in this study had the highest median 
number and the largest proportion of non-employee HCP. (Less difficulty reporting 
numerator data was reported by dialysis clinics and physician practices, which had few CNE 
or ONE.) Electronic tracking systems, often linked to existing databases or networks, have 
allowed hospitals to successfully track vaccination among both employees29,30,36–38 and 
various types of non-employee HCP29,37,38.
To ensure that the measure was feasible for use, CDC submitted for NQF endorsement a 
revised measure that limited the types of non-employees included. The CNE category, now 
called “licensed independent practitioners”, was restricted to non-employee physicians, 
advanced practice nurses, and physician assistants working at the healthcare facility. The 
ONE category, now called “adult students/trainees and volunteers,” was restricted to non-
employee students; trainees (including interns and residents); and volunteers aged ≥18 years 
working at the facility.
Only personnel working ≥30 days during the influenza season were included in the revised 
measure, in order to mitigate the difficulty of tracking temporary non-employee HCP with 
limited potential exposure. The revised measure is less comprehensive but is more likely to 
produce valid and reliable estimates of HCP vaccination coverage. The revised measure was 
fully endorsed by NQF in May 2012. The Centers for Medicare and Medicaid Services has 
added the NQF-endorsed measure to its quality reporting programs for acute care hospitals 
and ASCs, which will affect annual payment updates for these facilities.39,40
Limitations
These results are subject to certain limitations. Participating jurisdictions were selected on 
the basis of prior experience with or interest in reporting HCP influenza vaccination 
coverage, and facilities were not randomly recruited. Therefore, results may not be 
generalizable to all healthcare facilities nationally. Facilities with less experience in such 
measurement were less likely to complete the evaluation; these facilities may have 
experienced greater barriers to using the measure than those who completed the current 
study. However, respondents represented a variety of facility types: public and private, 
urban and non-urban, with various levels of prior experience measuring influenza 
vaccination (Table 1).
Conclusion
This study demonstrated that reporting HCP employee vaccination status using a 
standardized measure was feasible for most healthcare facilities. Measuring vaccination 
status among non-employee HCP, particularly those working in a facility for a limited time, 
remains difficult. Annual influenza vaccination is recommended for all paid and unpaid 
HCP with potential exposure to patients or infectious materials, in order to reduce risk of 
transmitting and acquiring influenza.22
As healthcare facilities gain experience using the NQF-endorsed measure, it can be adapted 
to include additional non-employee HCP. Continued implementation and expansion of the 
measure to additional HCP populations and settings will inform quality improvement efforts 
in healthcare facilities and facilitate national comparisons of HCP influenza vaccination 
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estimates. Despite efforts by numerous professional organizations, increasing HCP influenza 
vaccination coverage has been challenging. Enhancing measurement of HCP influenza 
vaccination using this standardized measure should lead to increased vaccination uptake, 
resulting in healthier patients and providers.
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Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors thank the following individuals for their significant contributions to the process of pilot-testing the 
HCP vaccination measure: Ms. Erica Boston, Dr. Robert Harrison, MD, Ms. Patricia McLendon, MPH, and Dr. Jon 
Rosenberg, MD from the California Department of Public Health; Dr. Joan Baumbach, MD and Ms. Lisa Bowdey 
from the New Mexico Department of Health; Mr. Edward Wake and Dr. Jane R. Zucker, MD, MSc from the New 
York City Department of Health and Mental Hygiene; Dr. Carol Friedman (deceased), DO, Dr. Taranisia 
MacCannell, PhD, and Dr. Cindy Weinbaum, MD, MPH from the CDC; and Ms. LaDora O. Woods, contractor 
with Carter Consulting.
None of the authors of this manuscript has any financial or proprietary interest in this work. This work was 
supported by the CDC.
References
1. Centers for Disease Control and Prevention. Estimates of deaths associated with seasonal influenza 
– United States. 1976–2007. MMWR Wkly Rep. 2010; 59(33):1057–1062.
2. Sartor C, Zandotti C, Romain F, et al. Disruption of services in an internal medicine unit due to a 
nosocomial influenza outbreak. Infect Control Hosp Epidemiol. 2002; 23:615–619. [PubMed: 
12400893] 
3. Bridges CB, Kuehnert MJ, Hall CB. Transmission of influenza: implications for control in 
healthcare settings. Clin Infect Dis. 2003:1094–1101. [PubMed: 14523774] 
4. Cunney RJ, Bialachowski A, Thornley D, Smaill FM, Pennie RA. An outbreak of influenza A in a 
neonatal intensive care unit. Infect Control Hosp Epidemiol. 2000; 21:449–454. [PubMed: 
10926394] 
5. Voirin N, Barret B, Metzger M-H, Vanhems P. Hospital-acquired influenza: A synthesis using the 
Outbreak Reports and Intervention Studies of Nosocomial Infection (ORION) statement. J Hosp 
Infect. 2009; 71:1–14. [PubMed: 18952319] 
6. Weinstock DM, Eagan J, Malak SA, et al. Control of influenza A on a bone marrow transplant unit. 
Infect Control Hosp Epidemiol. 2000; 21:730–732. [PubMed: 11089659] 
7. Wilde JA, McMillan JA, Serwint J, et al. Effectiveness of influenza vaccine in healthcare 
professionals: a randomized trial. JAMA. 1999; 281:908–913. [PubMed: 10078487] 
8. Lester RT, McGeer A, Tomlinson G, Detsky AS. Use of, effectiveness of, and attitudes regarding 
influenza vaccine among house staff. Infect Control Hosp Epidemiol. 2003; 24:839–844. [PubMed: 
14649772] 
9. Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving 
the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol. 2004; 25:923–928. 
[PubMed: 15566025] 
10. Lemaitre M, Meret T, Rothan-Tondeur M, et al. Effect of influenza vaccination of nursing home 
staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc. 2009; 57:1580–1586. 
[PubMed: 19682118] 
11. Burls A, Jordan R, Barton P, et al. Vaccinating healthcare workers against influenza to protect the 
vulnerable—Is it a good use of healthcare resources? A systematic review of the evidence and an 
economic evaluation. Vaccine. 2006; 24:4212–4221. [PubMed: 16546308] 
Lindley et al. Page 7
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
12. Saxen H, Virtanen M. Randomized, placebo-controlled double blind study on the efficacy of 
influenza immunization on absenteeism of healthcare workers. Pediatr Infect Dis J. 1999; 18:779–
783. [PubMed: 10493337] 
13. Hayward AC, Harling R, Wetten S, et al. Effectiveness of an influenza vaccine programme for care 
home staff to prevent death, morbidity, and health service use among residents: cluster randomised 
controlled trial. BMJ. 2006; 333:1241–1246. [PubMed: 17142257] 
14. Potter J, Stott DJ, Roberts MA, et al. Influenza vaccination of healthcare workers in long-term-care 
hospitals reduces the mortality of elderly patients. J. Infect Dis. 1997; 175:1–6. [PubMed: 
8985189] 
15. Van den Dool C, Bonten MJM, Hak E, Heijne JCM, Wallinga J. The effects of influenza 
vaccination of health care workers in nursing homes: insights from a mathematical model. PLoS 
Medicine. 2008; 5:1453–1460.
16. Oshitani H, Saito R, Seiki N, et al. Influenza vaccination levels and influenza-like illness in long-
term–care facilities for elderly people in Niigata, Japan, during an influenza A (H3N2) epidemic. 
Infect Control Hosp Epidemiol. 2000; 21:728–730. [PubMed: 11089658] 
17. Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who work 
with the elderly: systematic review. Vaccine. 2011; 29:344–356. [PubMed: 20937313] 
18. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers 
on mortality of elderly people in long-term care: A randomized controlled trial. Lancet. 2000; 
355:93–97. [PubMed: 10675165] 
19. New infection control requirement for offering influenza vaccination to staff and licensed 
independent practitioners. Jt Comm Perspect. 2006; 26:10–11.
20. National Foundation for Infectious Diseases. Bethesda, MD: 2004. Improving influenza 
vaccination rates in health care workers: strategies to increase protection for workers and patients. 
http://ideha.dhmh.maryland.gov/OIDEOR/IMMUN/Shared%20Documents/hcwmonograph.pdf.
21. Talbot TR, Babcock H, Caplan AL, et al. Revised SHEA position paper: Influenza vaccination of 
healthcare personnel. Infect Control Hosp Epidemiol. 2010; 31:987–995. [PubMed: 20807037] 
22. Pearson ML, Bridges CB, Harper SA. Healthcare Infection Control Practices Advisory Committee 
(HICPAC); Advisory Committee on Immunization Practices (ACIP). Influenza vaccination of 
health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory 
Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP) (published 
correction appears in MMWR Recomm Rep 2006; 55: 252). MMWR Recomm Rep. 2006; 
55(RR-2):1–16. [PubMed: 16498385] 
23. The Joint Commission. Prepublication standard IC.02.04.01: Influenza vaccination for licensed 
independent practitioners and staff. http://www.jointcommission.org/
influenza_vaccination_prepublication. 
24. Guide to Community Preventive Services. Universally recommended vaccinations: provider 
assessment & feedback (abbreviated). Review completed February 2008. 
www.thecommunityguide.org/vaccines/universally/providerassessment.html. 
25. Helms C, Polgreen P, Polgreen L, et al. Voluntary reporting of employee influenza vaccination 
rates by acute care hospitals in Iowa: the impact of a four year provider-based statewide 
performance improvement project. Vaccine. 2011; 29:3483–3488. [PubMed: 21439317] 
26. National Quality Forum. Measure Evaluation Criteria. 2011 Jan. http://www.qualityforum.org/
Measuring_Performance/Submitting_Standards/Measure_Evaluation_Criteria.aspx. 
27. Libby TE, Lindley MC, Lorick SA, et al. Reliability and validity of a standardized measure of 
influenza vaccination coverage among healthcare personnel. Infect Control Hosp Epidemiol. 2013 
(in press). 
28. MacCannell T, Shugart A, Schneider A, et al. A qualitative assessment of a performance measure 
for reporting influenza vaccination rates among healthcare personnel. Infect Control Hosp 
Epidemiol. 2012; 33(9):945–948. [PubMed: 22869270] 
29. Bertin M, et al. Novel use of the intranet to document health care personnel participation in a 
mandatory influenza vaccination reporting program. Am J Infect Control. 2007; 35:33–37. 
[PubMed: 17276789] 
Lindley et al. Page 8
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
30. Palmore TN, et al. A successful mandatory influenza vaccination campaign using an innovative 
electronic tracking system. Infect Control Hosp Epidemiol. 2009; 30:1137–1142. [PubMed: 
19860562] 
31. Bearman G, Fuentes L, Vorenkamp JVL, Drusin LM. Vaccination without documentation: 
influenza immunization among medical residents at a tertiary-care medical center. Infect Control 
Hosp Epidemiol. 2003; 24:626–628. [PubMed: 12940589] 
32. Russell ML, Henderson EA. The measurement of influenza vaccine coverage among health care 
workers. Am J Infect Control. 2003; 31:457–461. [PubMed: 14647106] 
33. McKibben L, Horan T, Tokars JI, et al. Guidance on public reporting of healthcare-associated 
infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. 
Am J Infect Control. 2005; 33:217–226. [PubMed: 15877016] 
34. Passaretti CL, Barclay P, Pronovost P, Perl TM. Public reporting of health care-associated 
infections (HAIs): approach to choosing HAI measures. Infect Control Hosp Epidemiol. 2011; 
32:768–774. [PubMed: 21768760] 
35. Lindley MC, Yonek J, Ahmed F, Perz JF, Torres GW. Measurement of influenza vaccination 
coverage among healthcare personnel in U.S. hospitals. Infect Control Hosp Epidemiol. 2009; 
30:1150–1157. [PubMed: 19848601] 
36. Melia M, et al. Development of a flexible, computerized database to prioritize, record, and report 
influenza vaccination rates for healthcare personnel. Infect Control Hosp Epidemiol. 2009; 
30:361–369. [PubMed: 19245312] 
37. Babcock HM, Gemeinhart N, Jones M, Dunagan WC, Woeltje KF. Mandatory influenza 
vaccination of health care workers: translating policy to practice. Clin Infect Dis. 2010; 50:459–
464. [PubMed: 20064039] 
38. Ribner BS, et al. A web-based program to ensure compliance of medical staff providers with 
mandated healthcare facility requirements. Am J Infect Control. 2011; 39:511–514. [PubMed: 
21496954] 
39. US Department of Health and Human Services. Medicare program; hospital inpatient prospective 
payment systems for acute care hospitals and the long-term care hospital prospective payment 
system and FY2012 rates; hospitals' FTE resident caps for graduate medical education payment; 
final rules. Federal Register. 2011; 76:51631–51633.
40. US Department of Health and Human Services. Medicare and Medicaid programs; hospital 
outpatient prospective payment; ambulatory surgical center payment; hospital value-based 
purchasing program; physician self-referral; and patient notification requirements in provider 
agreements; final rules. Federal Register. 2011; 76:74470–74472.
Lindley et al. Page 9
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Lindley et al. Page 10
Ta
bl
e 
1
Sa
m
pl
e 
ch
ar
ac
te
ris
tic
s o
ve
ra
ll 
an
d 
by
 fa
ci
lit
y 
ty
pe Al
l
Fa
ci
lit
ie
s
%
 (n
)
A
cu
te
 C
ar
e
H
os
pi
ta
ls
%
 (n
)
A
SC
%
 (n
)
D
ia
ly
sis
%
 (n
)
LT
C
F
%
 (n
)
Ph
ys
ic
ia
n
Pr
ac
tic
e
%
 (n
)
To
ta
l
10
0.
0 
(23
4)
10
0.
0 
(78
)
10
0.
0 
(16
)
10
0.
0 
(43
)
10
0.
0 
(59
)
10
0.
0 
(38
)
O
w
ne
rs
hi
p
 
 
Fo
r-
pr
of
it,
 p
riv
at
e
41
.9
 (9
8)
19
.2
 (1
5)
10
0.
0 
(16
)
58
.1
 (2
5)
44
.1
 (2
6)
42
.1
 (1
6)
 
 
N
ot
-fo
r-p
ro
fit
, p
riv
at
e
40
.2
 (9
4)
55
.1
 (4
3)
0.
0
39
.5
 (1
7)
35
.6
 (2
1)
34
.2
 (1
3)
 
 
Pu
bl
ic
, f
ed
er
al
 o
r s
ta
te
/lo
ca
l
18
.0
 (4
2)
25
.6
 (2
0)
0.
0
2.
3 
(1)
20
.3
 (1
2)
23
.7
 (9
)
A
re
a
 
 
U
rb
an
55
.1
 (1
29
)
57
.7
 (4
5)
62
.5
 (1
0)
48
.1
 (2
1)
52
.5
 (3
1)
57
.9
 (2
2)
 
 
Su
bu
rb
an
22
.7
 (5
3)
21
.8
 (1
7)
31
.3
 (5
)
27
.9
 (1
2)
27
.1
 (1
6)
7.
9 
(3)
 
 
R
ur
al
22
.2
 (5
2)
20
.5
 (1
6)
6.
3 
(1)
23
.3
 (1
0)
20
.3
 (1
2)
34
.2
 (1
3)
Pr
ev
io
us
 e
xp
er
ie
nc
e 
of
fe
rin
g 
H
CP
 in
flu
en
za
 v
ac
ci
ne
 
 
N
ev
er
 o
ffe
re
d
0.
9 
(2)
0.
0
12
.5
 (2
)
0.
0
0.
0
0.
0
 
 
O
ffe
re
d 
1–
4 
ye
ar
s
9.
8 
(22
)
5.
1 
(4)
12
.5
 (2
)
16
.3
 (7
)
13
.6
 (8
)
5.
3 
(2)
 
 
O
ffe
re
d 
5 
or
 m
or
e y
ea
rs
89
.3
 (2
09
)
94
.9
 (7
4)
75
.0
 (1
2)
83
.7
 (3
6)
86
.4
 (5
1)
94
.7
 (3
6)
Pr
ev
io
us
 e
xp
er
ie
nc
e 
m
ea
su
rin
g 
H
CP
 v
ac
ci
na
tio
n
 
 
N
ev
er
 m
ea
su
re
d
28
.2
 (6
6)
0.
0
93
.8
 (1
5)
23
.3
 (1
0)
28
.8
 (1
7)
63
.2
 (2
4)
 
 
M
ea
su
re
d 
du
rin
g 
20
09
–2
01
0 
on
ly
8.
1 
(19
)
2.
6 
(2)
0.
0
16
.3
 (7
)
11
.9
 (7
)
7.
9 
(3)
 
 
M
ea
su
re
d 
2–
4 
ye
ar
s
23
.5
 (5
5)
44
.9
 (3
5)
6.
3 
(1)
11
.6
 (5
)
15
.3
 (9
)
13
.2
 (5
)
 
 
M
ea
su
re
d 
5 
or
 m
or
e y
ea
rs
40
.2
 (9
4)
52
.6
 (4
1)
0.
0
48
.8
 (2
1)
44
.1
 (2
6)
15
.8
 (6
)
Fo
rm
al
ly
 sh
ar
e 
va
cc
in
at
io
n 
ra
te
s w
ith
 H
CP
 a
79
.8
 (1
34
)
82
.1
 (6
4)
10
0.
0 
(1)
81
.8
 (2
7)
71
.4
 (3
0)
85
.7
 (1
2)
Fa
ci
lit
y 
po
lic
y 
on
 H
CP
 v
ac
ci
na
tio
n 
b
 
 
R
ec
om
m
en
de
d 
bu
t n
ot
 re
qu
ire
d
39
.9
 (9
1)
24
.7
 (1
9)
50
.0
 (8
)
57
.1
 (2
4)
26
.3
 (1
5)
69
.4
 (2
5)
 
 
D
ec
lin
at
io
n 
re
qu
ire
d 
w
ith
 n
o 
co
ns
eq
ue
nc
es
54
.4
 (1
24
)
66
.2
 (5
1)
37
.5
 (6
)
40
.5
 (1
7)
68
.4
 (3
9)
30
.6
 (1
1)
 
 
D
ec
lin
at
io
n 
re
qu
ire
d 
w
ith
 c
on
se
qu
en
ce
s
3.
1 
(7)
7.
8 
(6)
0.
0
0.
0
1.
8 
(1)
0.
0
 
 
N
o 
po
lic
y
2.
6 
(6)
1.
3 
(1)
12
.5
 (2
)
2.
4 
(1)
3.
5 
(2)
0.
0
A
SC
: A
m
bu
la
to
ry
 S
ur
ge
ry
 C
en
te
r; 
LT
CF
: L
on
g-
Te
rm
 C
ar
e 
Fa
ci
lit
y;
 H
CP
: h
ea
lth
ca
re
 p
er
so
nn
el
.
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Lindley et al. Page 11
a
R
es
tri
ct
ed
 to
 th
os
e 
w
ho
 h
av
e 
pr
ev
io
us
ly
 m
ea
su
re
d 
in
flu
en
za
 v
ac
ci
na
tio
n 
ra
te
s a
m
on
g 
he
al
th
ca
re
 p
er
so
nn
el
.
b D
oe
s n
ot
 in
cl
ud
e 
“o
th
er
” 
re
sp
on
se
s t
ha
t c
ou
ld
 n
ot
 b
e 
ot
he
rw
ise
 c
at
eg
or
iz
ed
.
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Lindley et al. Page 12
Ta
bl
e 
2
R
es
ul
ts 
fo
r s
el
ec
te
d 
su
rv
ey
 e
le
m
en
ts 
on
 e
as
e 
of
 u
sin
g 
m
ea
su
re
, o
ve
ra
ll 
an
d 
by
 fa
ci
lit
y 
ty
pe
A
ll
Fa
ci
lit
ie
s
%
 (n
)
A
cu
te
 C
ar
e
H
os
pi
ta
ls
%
 (n
)
A
SC
%
 (n
)
D
ia
ly
sis
%
 (n
)
LT
C
F
%
 (n
)
Ph
ys
ic
ia
n
Pr
ac
tic
e
%
 (n
)
A
gr
ee
m
en
t f
or
 C
D
C 
to
ol
 e
le
m
en
ts
 
 
Ea
sy
 to
 u
se
74
.4
 (1
74
)
74
.4
 (5
8)
68
.8
 (1
1)
72
.1
 (3
1)
81
.4
 (4
8)
68
.4
 (2
6)
 
 
Co
m
pr
eh
en
siv
e
76
.1
 (1
78
)
71
.8
 (5
6)
75
.0
 (1
2)
76
.7
 (3
3)
81
.4
 (4
8)
76
.3
 (2
9)
 
 
R
el
ev
an
t t
o 
m
y 
he
al
th
ca
re
 fa
ci
lit
y
68
.0
 (1
59
)
73
.1
 (5
7)
50
.0
 (8
)
69
.8
 (3
0)
76
.3
 (4
5)
50
.0
 (1
9)
 
 
In
st
ru
ct
io
ns
 w
er
e 
ea
sy
 to
 u
nd
er
sta
nd
70
.1
 (1
64
)
73
.1
 (5
7)
50
.0
 (8
)
67
.4
 (2
9)
76
.3
 (4
5)
65
.8
 (2
5)
 
 
D
ef
in
iti
on
s w
er
e 
ea
sy
 to
 u
nd
er
sta
nd
68
.4
 (1
60
)
70
.5
 (5
5)
68
.8
 (1
1)
65
.1
 (2
8)
81
.4
 (4
8)
47
.4
 (1
8)
 
 
W
ou
ld
 re
co
m
m
en
d 
to
 o
th
er
 h
ea
lth
ca
re
 fa
ci
lit
ie
s
63
.7
 (1
49
)
70
.5
 (5
5)
43
.8
 (7
)
58
.1
 (2
5)
69
.5
 (4
1)
55
.3
 (2
1)
A
gr
ee
m
en
t f
or
 e
as
e 
of
 a
ss
ig
ni
ng
 H
CP
 to
 c
or
re
ct
 d
en
om
in
at
or
 c
at
eg
or
y 
a
 
 
Em
pl
oy
ee
s
82
.1
 (1
92
)
83
.3
 (6
5)
87
.5
 (1
4)
83
.7
 (3
6)
83
.1
 (4
9)
73
.7
 (2
8)
 
 
Cr
ed
en
tia
le
d 
no
n-
em
pl
oy
ee
s
51
.7
 (1
21
)
41
.0
 (3
2)
87
.5
 (1
4)
72
.1
 (3
1)
47
.5
 (2
8)
42
.1
 (1
6)
 
 
O
th
er
 n
on
-e
m
pl
oy
ee
s
44
.4
 (1
04
)
39
.7
 (3
1)
50
.0
 (8
)
55
.8
 (2
4)
49
.2
 (2
9)
31
.6
 (1
2)
A
gr
ee
m
en
t f
or
 e
as
e 
of
 c
ou
nt
in
g 
H
CP
 a
 
 
Em
pl
oy
ee
s
83
.3
 (1
95
)
80
.8
 (6
3)
93
.8
 (1
5)
83
.7
 (3
6)
84
.8
 (5
0)
81
.6
 (3
1)
 
 
Cr
ed
en
tia
le
d 
no
n-
em
pl
oy
ee
s
47
.9
 (1
12
)
32
.1
 (2
5)
81
.3
 (1
3)
69
.8
 (3
0)
39
.0
 (2
3)
55
.3
 (2
1)
 
 
O
th
er
 n
on
-e
m
pl
oy
ee
s
37
.6
 (8
8)
24
.4
 (1
9)
43
.8
 (7
)
51
.2
 (2
2)
35
.6
 (2
1)
50
.0
 (1
9)
A
SC
: A
m
bu
la
to
ry
 S
ur
ge
ry
 C
en
te
r; 
LT
CF
: L
on
g-
Te
rm
 C
ar
e 
Fa
ci
lit
y;
 H
CP
: h
ea
lth
ca
re
 p
er
so
nn
el
.
a
Pr
op
or
tio
n 
re
sp
on
di
ng
 “
ea
sy
” 
or
 “
ve
ry
 e
as
y”
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Lindley et al. Page 13
Ta
bl
e 
3
M
ajo
r b
arr
ier
s t
o r
ep
ort
ing
 H
CP
 in
flu
en
za 
va
cci
na
tio
n u
sin
g m
eas
ure
, o
ve
ral
l a
nd
 by
 fa
cil
ity
 ty
pe
 a
A
ll
Fa
ci
lit
ie
s
%
 (n
)
A
cu
te
 C
ar
e
H
os
pi
ta
ls
%
 (n
)
A
SC
%
 (n
)
D
ia
ly
sis
%
 (n
)
LT
C
F
%
 (n
)
Ph
ys
ic
ia
n
Pr
ac
tic
e
%
 (n
)
A
bi
lit
y 
to
 d
et
er
m
in
e 
va
cc
in
at
io
n 
sta
tu
s o
f o
th
er
 n
on
-e
m
pl
oy
ee
s
27
.4
 (6
4)
29
.5
 (2
3)
37
.5
 (6
)
25
.6
 (1
1)
32
.2
 (1
9)
13
.2
 (5
)
A
bi
lit
y 
to
 d
et
er
m
in
e 
va
cc
in
at
io
n 
sta
tu
s o
f c
re
de
nt
ia
le
d 
no
n-
em
pl
oy
ee
s
23
.5
 (5
5)
38
.5
 (3
0)
31
.3
 (5
)
9.
3 
(4)
25
.4
 (1
5)
2.
6 
(1)
D
et
er
m
in
in
g 
va
cc
in
at
io
n 
sta
tu
s o
f H
CP
 v
ac
ci
na
te
d 
ou
tsi
de
 th
e 
fa
ci
lit
y
21
.4
 (5
0)
29
.5
 (2
3)
18
.8
 (3
)
7.
0 
(3)
27
.1
 (1
6)
13
.2
 (5
)
N
um
be
r o
f o
th
er
 n
on
-e
m
pl
oy
ee
s w
or
ki
ng
 a
t f
ac
ili
ty
20
.9
 (4
9)
24
.5
 (2
3)
12
.5
 (2
)
16
.3
 (7
)
23
.7
 (1
4)
7.
9 
(3)
Ti
m
e 
re
qu
ire
d 
to
 c
ol
le
ct
 d
at
a 
on
 v
ac
ci
na
tio
n 
sta
tu
s o
f c
re
de
nt
ia
le
d 
no
n-
em
pl
oy
ee
s
20
.5
 (4
8)
37
.2
 (2
9)
31
.3
 (5
)
14
.0
 (6
)
13
.6
 (8
)
0.
0
Ti
m
e 
re
qu
ire
d 
to
 c
ol
le
ct
 d
at
a 
on
 v
ac
ci
na
tio
n 
sta
tu
s o
f o
th
er
 n
on
-e
m
pl
oy
ee
s
20
.1
 (4
7)
26
.9
 (2
1)
37
.5
 (6
)
16
.3
 (7
)
18
.6
 (1
1)
5.
3 
(2)
N
um
be
r o
f c
re
de
nt
ia
le
d 
no
n-
em
pl
oy
ee
s w
or
ki
ng
 a
t f
ac
ili
ty
13
.7
 (3
2)
28
.2
 (2
2)
12
.5
 (2
)
4.
7 
(2)
10
.2
 (6
)
0.
0
In
ad
eq
ua
te
 e
xi
sti
ng
 p
ro
ce
ss
 o
r s
ys
te
m
 in
 p
la
ce
 to
 tr
ac
k 
H
CP
 v
ac
ci
na
tio
n
10
.7
 (2
5)
9.
0 
(7)
18
.8
 (3
)
4.
7 
(2)
13
.6
 (8
)
13
.2
 (5
)
D
ef
in
iti
on
s o
f H
CP
 g
ro
up
s d
id
 n
ot
 m
at
ch
 th
os
e 
us
ed
 a
t f
ac
ili
ty
7.
7 
(18
)
14
.1
 (1
1)
6.
3 
(1)
2.
3 
(1)
1.
7 
(1)
10
.5
 (4
)
Ti
m
e 
re
qu
ire
d 
to
 c
ol
le
ct
 d
at
a 
on
 v
ac
ci
na
tio
n 
sta
tu
s o
f e
m
pl
oy
ee
s
7.
7 
(18
)
10
.3
 (8
)
6.
3 
(1)
4.
7 
(2)
8.
5 
(5)
5.
3 
(2)
Ti
m
e 
re
qu
ire
d 
to
 e
nt
er
 d
at
a 
on
 v
ac
ci
na
tio
n 
sta
tu
s o
f H
CP
7.
7 
(18
)
11
.5
 (9
)
18
.8
 (3
)
2.
3 
(1)
5.
1 
(3)
5.
3 
(2)
A
bi
lit
y 
to
 d
et
er
m
in
e 
va
cc
in
at
io
n 
sta
tu
s o
f e
m
pl
oy
ee
s
7.
3 
(17
)
5.
1 
(4)
6.
3 
(1)
4.
7 
(2)
11
.9
 (7
)
7.
9 
(3)
D
ist
in
gu
ish
in
g 
be
tw
ee
n 
m
ed
ic
al
 &
 n
on
-m
ed
ic
al
 re
as
on
s f
or
 d
ec
lin
at
io
n
6.
8 
(16
)
10
.3
 (8
)
6.
3 
(1)
4.
7 
(2)
5.
1 
(3)
5.
3 
(2)
La
ck
 o
f t
im
e 
to
 p
re
pa
re
 p
rio
r t
o 
re
po
rti
ng
 p
er
io
d
6.
8 
(16
)
9.
0 
(7)
6.
3 
(1)
2.
3 
(1)
8.
5 
(5)
5.
3 
(2)
Pr
iv
ac
y 
co
nc
er
ns
 re
po
rte
d 
by
 in
di
vi
du
al
 H
CP
5.
1 
(12
)
6.
4 
(5)
6.
3 
(1)
2.
3 
(1)
5.
1 
(3)
5.
3 
(2)
A
SC
: A
m
bu
la
to
ry
 S
ur
ge
ry
 C
en
te
r; 
LT
CF
: L
on
g-
Te
rm
 C
ar
e 
Fa
ci
lit
y;
 H
CP
: h
ea
lth
ca
re
 p
er
so
nn
el
. F
ac
ili
tie
s c
ou
ld
 re
po
rt 
m
ul
tip
le
 b
ar
rie
rs
, s
o 
re
sp
on
se
s m
ay
 su
m
 to
 g
re
at
er
 th
an
 1
00
%
.
a
Ite
m
s r
ep
or
te
d 
as
 “
m
ajo
r b
arr
ier
s” 
(vs
. “
som
ew
ha
t o
f a
 ba
rri
er”
 or
 “n
ot 
a b
arr
ier
 at
 al
l”)
 to
 us
ing
 th
e N
QF
 m
eas
ure
 fo
r r
ep
ort
ing
 H
CP
 in
flu
en
za 
va
cci
na
tio
n b
y <
5%
 of
 fa
cil
itie
s o
ve
ral
l w
ere
: la
ck
 of
 
pr
ev
io
us
 e
xp
er
ie
nc
e 
m
ea
su
rin
g 
H
CP
 in
flu
en
za
 v
ac
ci
na
tio
n,
 th
e 
nu
m
be
r o
f e
m
pl
oy
ee
s w
or
ki
ng
 a
t t
he
 h
ea
lth
ca
re
 fa
ci
lit
y,
 la
ck
 o
f s
up
po
rt 
fro
m
 a
dm
in
ist
ra
tio
n 
or
 le
ad
er
sh
ip
 fo
r u
sin
g 
th
e 
m
ea
su
re
, l
ac
k 
of
 
su
pp
or
t o
r a
ss
ist
an
ce
 fr
om
 o
th
er
 st
af
f m
em
be
rs
 in
 tr
ac
ki
ng
 v
ac
ci
na
tio
n,
 u
nd
er
sta
nd
in
g 
th
e 
de
fin
iti
on
s f
or
 d
iff
er
en
t t
yp
es
 o
f H
CP
, p
riv
ac
y 
co
nc
er
ns
 re
po
rte
d 
by
 u
ni
on
s, 
an
d 
ot
he
r.
Am J Prev Med. Author manuscript; available in PMC 2015 November 25.
